Catatonia induced by substances or medications

Description

Catatonia induced by substances or medications is a syndrome of primarily psychomotor disturbances, characterized by the co-occurrence of several symptoms of decreased, increased, or abnormal psychomotor activity, which develops during or soon after intoxication or withdrawal from certain psychoactive substances, including phencyclidine (PCP), cannabis, hallucinogens such as mescaline or LSD, cocaine and MDMA or related drugs, or during the use of certain psychoactive and non-psychoactive medications (e.g. antipsychotic medications, benzodiazepines, steroids, disulfiram, ciprofloxacin).

Index terms

Catatonia induced by substances or medications
Catatonia induced by psychoactive substances, including medications
Catatonia induced by specified psychoactive substance or medication

Show allHide

Catatonia induced by unknown or unspecified psychoactive substance

Excludes

8A0Y – Neuroleptic malignant syndrome
8D85 – Serotonin syndrome

Exclusions from above levels

NE60 – Harmful effects of drugs, medicaments or biological substances, not elsewhere classified
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6A40 – Catatonia associated with another mental disorder
6A4Z – Catatonia, unspecified

Foundation entity

Catatonia induced by substances or medications – http://id.who.int/icd/entity/289492002

Allowed postcoordination axes

Part of: 06: Mental, behavioural or neurodevelopmental disorders